CASI
LIVE

Serial Number

87892837

Owner

CASI PHARMACEUTICALS, INC.

Attorney

Stacey J. Watson

First Use Date

Jun 16, 2014

Filing Date

Apr 25, 2018

Add to watchlist:

No watchlists yet
View on USPTO

CASI Trademark

Serial Number: 87892837 • Registration: 5748674

CASI is a trademark filed by CASI PHARMACEUTICALS, INC. on April 25, 2018. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

CASI PHARMACEUTICALS, INC. (11 trademarks)

Rockville, MD 20850

Entity Type: 03

Trademark Details

Filing Date

April 25, 2018

Registration Date

May 14, 2019

First Use Anywhere

June 16, 2014

First Use in Commerce

June 16, 2014

Published for Opposition

February 26, 2019

Goods & Services

Pharmaceutical research and development; development of pharmaceutical preparations and medicines; provision of scientific information via Internet portals in the field of medical research and biotechnology; Product development research and product development in the field of pharmaceutical, biological and biotechnological products; medical research and product development services in the field of treatments for cancer, cardiovascular, metabolic, inflammatory, nervous system, anti-infective, and dermatological conditions; pharmaceutical research and development of human therapeutics using gene editing; Drug discovery services; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research on the subject of pharmaceuticals; Biochemical research and development; Biological research; Biomedical research services; Clinical research in the field of cancer; Conducting clinical trials for others in the field of cancer; Conducting early evaluations in the field of new pharmaceuticals; Genotyping services for research or analysis purposes; Laboratory research services relating to pharmaceuticals; Medical research; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical research services; Product research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research; Scientific research and development; Stem cell research; Technical research in the field of pharmaceutical studies

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Mar 31, 2025 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Mar 31, 2025 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 31, 2025 APRE
TEAS SECTION 8 & 15 RECEIVED
Dec 12, 2024 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 14, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
May 14, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 26, 2019 NPUB
PUBLISHED FOR OPPOSITION
Feb 26, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 6, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 16, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 16, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 16, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 16, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 16, 2018 GNRN
NON-FINAL ACTION E-MAILED
Aug 16, 2018 GNRT
NON-FINAL ACTION WRITTEN
Aug 16, 2018 CNRT
ASSIGNED TO EXAMINER
Aug 16, 2018 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
May 9, 2018 AMPX
ASSIGNED TO LIE
May 6, 2018 ALIE
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 4, 2018 NWOS
TEAS VOLUNTARY AMENDMENT RECEIVED
May 1, 2018 PARI
NEW APPLICATION ENTERED
Apr 28, 2018 NWAP